These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 7889627

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A (Sipple's syndrome).
    Oishi S, Sato T, Takiguchi-Shirahama S, Nakamura Y.
    Endocr J; 1995 Aug; 42(4):527-36. PubMed ID: 8556060
    [Abstract] [Full Text] [Related]

  • 4. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects.
    Beldjord C, Desclaux-Arramond F, Raffin-Sanson M, Corvol JC, De Keyzer Y, Luton JP, Plouin PF, Bertagna X.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2063-8. PubMed ID: 7608256
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland.
    Padberg BC, Schröder S, Jochum W, Kastendieck H, Roth J, Heitz PU, Komminoth P.
    Am J Pathol; 1995 Dec; 147(6):1600-7. PubMed ID: 7495285
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G, Domené HM, Iorcansky S, Barontini M.
    Medicina (B Aires); 1998 Dec; 58(2):179-84. PubMed ID: 9706252
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The RET proto-oncogene and cancer.
    Donis-Keller H.
    J Intern Med; 1995 Oct; 238(4):319-25. PubMed ID: 7595167
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing.
    Komminoth P, Kunz E, Hiort O, Schröder S, Matias-Guiu X, Christiansen G, Roth J, Heitz PU.
    Am J Pathol; 1994 Oct; 145(4):922-9. PubMed ID: 7943181
    [Abstract] [Full Text] [Related]

  • 14. Absence of mutations at codon 768 of the RET proto-oncogene in sporadic and hereditary pheochromocytomas.
    Yoshimoto K, Kimura T, Tanaka C, Moritani M, Iwahana H, Itakura M.
    Endocr J; 1996 Feb; 43(1):109-14. PubMed ID: 8732460
    [Abstract] [Full Text] [Related]

  • 15. Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.
    Moers AM, Landsvater RM, Schaap C, Jansen-Schillhorn van Veen JM, de Valk IA, Blijham GH, Höppener JW, Vroom TM, van Amstel HK, Lips CJ.
    Am J Med; 1996 Dec; 101(6):635-41. PubMed ID: 9003111
    [Abstract] [Full Text] [Related]

  • 16. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.
    Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L.
    Nature; 1993 Jun 03; 363(6428):458-60. PubMed ID: 8099202
    [Abstract] [Full Text] [Related]

  • 17. Mutations in the cysteine-rich region of the RET proto-oncogene in patients diagnosed as having sporadic medullary thyroid carcinoma.
    Kimura T, Yoshimoto K, Yokogoshi Y, Saito S.
    Endocr J; 1995 Aug 03; 42(4):517-25. PubMed ID: 8556059
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Germline RET proto-oncogene mutations in two Taiwanese families with multiple endocrine neoplasia type 2A.
    Wu SL, Chang TC, Huang CN, Chuang LM, Chang TJ.
    J Formos Med Assoc; 1998 Sep 03; 97(9):614-8. PubMed ID: 9795529
    [Abstract] [Full Text] [Related]

  • 20. Germline mutations of the RET proto-oncogene in eight Japanese patients with multiple endocrine neoplasia type 2A (MEN2A).
    Takiguchi-Shirahama S, Koyama K, Miyauchi A, Wakasugi T, Oishi S, Takami H, Hikiji K, Nakamura Y.
    Hum Genet; 1995 Feb 03; 95(2):187-90. PubMed ID: 7860065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.